Nakamura I - Search Results

1

Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.

Nakamura I, Takahashi N, Sasaki T, Tanaka S, Udagawa N, Murakami H, Kimura K, Kabuyama Y, Kurokawa T, Suda T, et al. Nakamura I, et al. FEBS Lett. 1995 Mar 13;361(1):79-84. doi: 10.1016/0014-5793(95)00153-z. FEBS Lett. 1995. PMID: 7890044 Free article.

2

Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption.

Tanaka S, Takahashi N, Udagawa N, Murakami H, Nakamura I, Kurokawa T, Suda T. Tanaka S, et al. Among authors: nakamura i. J Cell Biochem. 1995 Aug;58(4):424-35. doi: 10.1002/jcb.240580405. J Cell Biochem. 1995. PMID: 7593264

3

The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts.

Zhang D, Udagawa N, Nakamura I, Murakami H, Saito S, Yamasaki K, Shibasaki Y, Morii N, Narumiya S, Takahashi N, et al. Zhang D, et al. Among authors: nakamura i. J Cell Sci. 1995 Jun;108 ( Pt 6):2285-92. doi: 10.1242/jcs.108.6.2285. J Cell Sci. 1995. PMID: 7673348

4

A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.

Murakami H, Takahashi N, Sasaki T, Udagawa N, Tanaka S, Nakamura I, Zhang D, Barbier A, Suda T. Murakami H, et al. Among authors: nakamura i. Bone. 1995 Aug;17(2):137-44. doi: 10.1016/s8756-3282(95)00150-6. Bone. 1995. PMID: 8554921

5

Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.

Nakamura I, Takahashi N, Sasaki T, Jimi E, Kurokawa T, Suda T. Nakamura I, et al. J Bone Miner Res. 1996 Dec;11(12):1873-9. doi: 10.1002/jbmr.5650111207. J Bone Miner Res. 1996. PMID: 8970888

6

Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice.

Nakamura I, Takahashi N, Udagawa N, Moriyama Y, Kurokawa T, Jimi E, Sasaki T, Suda T. Nakamura I, et al. FEBS Lett. 1997 Jan 20;401(2-3):207-12. doi: 10.1016/s0014-5793(96)01454-8. FEBS Lett. 1997. PMID: 9013888 Free article.

7

Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.

Murakami H, Takahashi N, Tanaka S, Nakamura I, Udagawa N, Nakajo S, Nakaya K, Abe M, Yuda Y, Konno F, Barbier A, Suda T. Murakami H, et al. Among authors: nakamura i. Bone. 1997 May;20(5):399-404. doi: 10.1016/s8756-3282(97)00025-2. Bone. 1997. PMID: 9145236

8

Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts.

Nakamura I, Sasaki T, Tanaka S, Takahashi N, Jimi E, Kurokawa T, Kita Y, Ihara S, Suda T, Fukui Y. Nakamura I, et al. J Cell Physiol. 1997 Aug;172(2):230-9. doi: 10.1002/(SICI)1097-4652(199708)172:2<230::AID-JCP10>3.0.CO;2-D. J Cell Physiol. 1997. PMID: 9258344

9

Modulation of osteoclast differentiation by local factors.

Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. Suda T, et al. Among authors: nakamura i. Bone. 1995 Aug;17(2 Suppl):87S-91S. doi: 10.1016/8756-3282(95)00185-g. Bone. 1995. PMID: 8579904 Review.

10

Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact.

Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, Takahashi N, Suda T. Jimi E, et al. Among authors: nakamura i. Endocrinology. 1996 May;137(5):2187-90. doi: 10.1210/endo.137.5.8612568. Endocrinology. 1996. Corrected and republished in: Endocrinology. 1996 Aug;137(8):2187-90. doi: 10.1210/endo.137.8.8754795 PMID: 8612568 Corrected and republished.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,147 results

Search Page

Filters